Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - Alexion Q4 topline up 15% profit beats
February, 04 2021 09:21 AM
Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals (
ALXN ) Q4 results:Revenues: $1.59B (+15.2% Y/Y), beats by $80M.Key product sales: Soliris: $1.02B (+1%); Ultomiris: $313.5M (+84%); Strensiq: $185.9M (+11%); Andexxa: $39.6M; Kanuma: $29.2M (-14%).Net income: $535.8M (-40%); non-GAAP net income: $664.5M (+9%); EPS: $2.42; non-GAAP EPS: $2.96, beats by 40 cents.Cash and cash equivalents and restricted cash as of Dec 31 2020: $3.03B.Alexion shares up nearly 1% premarket.Previously (Feb. 4): Alexion Pharmaceuticals EPS beats by $0.40, beats on revenue.
For further details see:
Alexion Q4 topline up 15%, profit beats
Stock Information
Company Name:
Alexion Pharmaceuticals Inc.
Stock Symbol:
ALXN
Market:
NASDAQ
Website:
alexion.com
Get ALXN Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .